Eva L Feldman Selected Research

NAD (NADH)

2/2021	Differential effects of minocycline on microvascular complications in murine models of type 1 and type 2 diabetes.
1/2021	Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects.
12/2020	Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy.
12/2020	Statin Therapy and Risk of Polyneuropathy in Type 2 Diabetes: A Danish Cohort Study.
10/2020	Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes.
1/2020	Metabolic Factors, Lifestyle Habits, and Possible Polyneuropathy in Early Type 2 Diabetes: A Nationwide Study of 5,249 Patients in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Cohort.
1/2020	Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy.
1/2020	Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
1/2019	Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes.
1/2019	Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eva L Feldman Research Topics

Disease

43	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2007
42	Diabetic Neuropathies (Diabetic Neuropathy) 01/2021 - 10/2002
35	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 07/2004
29	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 03/2004
20	Hyperglycemia 01/2022 - 08/2004
18	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2020 - 12/2007
13	Dyslipidemias (Dyslipidemia) 01/2022 - 10/2009
12	Neuroblastoma 05/2010 - 07/2002
10	Obesity 01/2022 - 01/2017
10	Pain (Aches) 01/2021 - 10/2008
10	Diabetes Complications 01/2021 - 10/2005
10	Insulin Resistance 01/2020 - 12/2003
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 09/2015
8	Inflammation (Inflammations) 01/2022 - 01/2012
8	Diabetic Nephropathies (Diabetic Nephropathy) 02/2021 - 10/2008
7	Prediabetic State (Prediabetes) 01/2022 - 01/2005
7	Mitochondrial Diseases (Mitochondrial Disease) 12/2021 - 11/2002
7	Polyneuropathies (Polyneuropathy) 12/2020 - 01/2005
6	Neoplasms (Cancer) 01/2021 - 07/2002
6	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2018 - 03/2005
5	Neuralgia (Stump Neuralgia) 01/2020 - 10/2002
5	Alzheimer Disease (Alzheimer's Disease) 12/2019 - 09/2011
4	Nervous System Diseases (Neurological Disorders) 01/2019 - 01/2005
3	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2021 - 02/2006
3	Kidney Diseases (Kidney Disease) 10/2020 - 10/2011
3	Hypertension (High Blood Pressure) 01/2018 - 12/2014
3	Hyperinsulinism (Hyperinsulinemia) 01/2017 - 10/2011
3	Disease Progression 05/2015 - 08/2010
3	Motor Neuron Disease (Primary Lateral Sclerosis) 02/2012 - 12/2008
3	Hyperalgesia 01/2012 - 11/2009
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 06/2006
2	Chronic Pain 01/2022 - 08/2014
2	Nerve Degeneration 01/2022 - 01/2019
2	Central Nervous System Diseases (CNS Diseases) 01/2021 - 01/2021
2	Neuroinflammatory Diseases 01/2021 - 05/2004
2	Weight Loss (Weight Reduction) 01/2020 - 01/2017
2	Albuminuria 01/2020 - 11/2019
2	Amyloid Plaque 12/2019 - 10/2018
2	Muscular Atrophy (Muscle Atrophy) 11/2019 - 11/2011
2	Wounds and Injuries (Trauma) 09/2019 - 04/2015
2	Diabetes Mellitus 12/2016 - 06/2012
2	Weight Gain 01/2016 - 09/2015
2	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2016 - 02/2009
2	Glucose Intolerance 04/2015 - 01/2005
2	Hyperlipidemias (Hyperlipidemia) 12/2014 - 01/2013

Drug/Important Bio-Agent (IBA)

26	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2002
26	NAD (NADH)IBA 02/2021 - 06/2008
16	Insulin (Novolin)FDA Link 01/2022 - 10/2008
14	LipidsIBA 01/2022 - 09/2011
10	Insulin-Like Growth Factor I (IGF-1)IBA 12/2019 - 01/2004
7	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 05/2012
7	Triglycerides (Triacylglycerol)IBA 01/2020 - 07/2009
6	CholesterolIBA 01/2021 - 09/2015
6	Streptozocin (Streptozotocin)FDA Link 10/2020 - 12/2007
6	Proteins (Proteins, Gene)FDA Link 12/2019 - 02/2009
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
5	Pioglitazone (Actos)FDA Link 03/2019 - 09/2015
4	Retinaldehyde (Retinal)IBA 10/2020 - 10/2011
4	Pharmaceutical PreparationsIBA 01/2019 - 01/2008
4	Glutamic Acid (Glutamate)FDA Link 05/2017 - 03/2005
4	EnzymesIBA 05/2016 - 04/2005
4	Biological ProductsIBA 03/2016 - 10/2010
4	AntioxidantsIBA 03/2009 - 08/2004
4	Mannitol (Osmitrol)FDA LinkGeneric 06/2005 - 07/2002
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2005
3	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2016
3	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 01/2018
3	Opioid Analgesics (Opioids)IBA 01/2020 - 06/2011
3	HDL CholesterolIBA 01/2020 - 01/2013
3	oxidized low density lipoproteinIBA 01/2017 - 10/2009
3	LDL CholesterolIBA 01/2017 - 01/2013
3	Leptin ReceptorsIBA 05/2016 - 05/2010
3	LeptinIBA 03/2016 - 01/2013
3	LigandsIBA 11/2015 - 02/2007
3	Nerve Growth Factor (NGF)IBA 01/2012 - 11/2009
3	Caspase 3 (Caspase-3)IBA 10/2010 - 12/2007
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
2	CalciumIBA 12/2021 - 02/2009
2	Matrix Metalloproteinases (MMPs)IBA 12/2021 - 07/2002
2	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 09/2019
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020 - 11/2015
2	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 11/2015
2	C-PeptideIBA 01/2020 - 03/2016
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 03/2009
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2020 - 11/2015
2	Superoxide Dismutase-1IBA 11/2019 - 02/2011
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019 - 01/2016
2	2,4-thiazolidinedione (thiazolidinedione)IBA 05/2016 - 09/2015
2	Apolipoprotein B-48IBA 03/2016 - 01/2013
2	Apolipoproteins E (ApoE)IBA 03/2016 - 01/2013
2	ApolipoproteinsIBA 03/2016 - 01/2013
2	polyolIBA 03/2016 - 10/2002

Therapy/Procedure

47	Therapeutics 01/2022 - 03/2004
12	Glycemic Control 02/2021 - 08/2010
8	Stem Cell Transplantation 01/2021 - 08/2012
7	Transplantation 10/2018 - 06/2012
4	Surgical Amputation (Amputations) 01/2022 - 10/2008
3	Drug Therapy (Chemotherapy) 01/2021 - 07/2002
2	Bariatric Surgery 01/2020 - 01/2017
2	Spinal Injections 01/2019 - 06/2012